215-145-7

应用筛选条件

关键词:'215-145-7'

显示 1-30 共 87 条结果关于 "215-145-7" 范围技术文档

2,2,4–Trimethylpentane 0.692 98–99 –107 –7 0.5 1.94 215 1.391 Water 1 100 0 — 1 78.54 145 –23 32 0.81 2.57 288 1.505 p–Xylene 0.866

Lab Notebook Guidelines

2,2,4–Trimethylpentane 0.692 98–99 –107 –7 0.5 1.94 215 1.391 Water 1 100 0 — 1 78.54 145 –23 32 0.81 2.57 288 1.505 p–Xylene 0.866

LABORATORY NOTEBOOK ISSUANCE PAGE

2,2,4–Trimethylpentane 0.692 98–99 –107 –7 0.5 1.94 215 1.391 Water 1 100 0 — 1 78.54 145 –23 32 0.81 2.57 288 1.505 p–Xylene 0.866

LABORATORY NOTEBOOK ISSUANCE PAGE

2,2,4–Trimethylpentane 0.692 98–99 –107 –7 0.5 1.94 215 1.391 Water 1 100 0 — 1 78.54 145 –23 32 0.81 2.57 288 1.505 p–Xylene 0.866

Data Sheet - D3816

et al., J. Biol. Chem., 274, 33945-33950 (1999). 10. Shirao, T., et al., Exp. Cell Res., 215, 145-153 (1994). 11. Asada, H., et al., J. Neurosci. Res., 38, 149-159 (1994). 12.

Data Sheet - 31404

, Biochim. Biophys. Acta, 204, 478 (1970). 22. Walter, H. and Johansson, G., Anal. Biochem., 155, 215, (1986). 23. Sanders, F.K. and Smith, J.D., Nature, 227, 513 (1970). 24. Sasaki, S and Noguchi, H

Data Sheet - 31395

, Biochim. Biophys. Acta, 204, 478 (1970). 22. Walter, H. and Johansson, G., Anal. Biochem., 155, 215, (1986). 23. Sanders, F.K. and Smith, J.D., Nature, 227, 513 (1970). 24. Sasaki, S and Noguchi, H

Data Sheet - 31403

, Biochim. Biophys. Acta, 204, 478 (1970). 22. Walter, H. and Johansson, G., Anal. Biochem., 155, 215, (1986). 23. Sanders, F.K. and Smith, J.D., Nature, 227, 513 (1970). 24. Sasaki, S and Noguchi, H

Data Sheet - 31396

, Biochim. Biophys. Acta, 204, 478 (1970). 22. Walter, H. and Johansson, G., Anal. Biochem., 155, 215, (1986). 23. Sanders, F.K. and Smith, J.D., Nature, 227, 513 (1970). 24. Sasaki, S and Noguchi, H

Data Sheet - L6787

211 NS 2028 N5501 NG-Nitro-L-arginine N7778 7-Nitroindazole O0886 Olomoucine O3636 ODQ P-106 3-Phenylpropargylamine hydrochloride P-215 PD 098,059 P3510 Papaverine hydrochloride R

Product Information - L6787

211 NS 2028 N5501 NG-Nitro-L-arginine N7778 7-Nitroindazole O0886 Olomoucine O3636 ODQ P-106 3-Phenylpropargylamine hydrochloride P-215 PD 098,059 P3510 Papaverine hydrochloride R

Product Information Sheet - T7254

al., Agents Actions, 36, 243, (1992). 31. Griscavage, J.M. et al., Biochem. Biophys. Res. Commun., 215, 721, (1995). 32. Fearnhead, H.O. et al. Toxicol. Lett., 82/83, 135, (1995). 33. Grammer, T.C. and

XP725 Antibody Number-Lot Number 071M4826

256 277 278 279 280 3.5 209 210 211 212 233 234 235 236 257 258 259 260 281 282 283 284 3.6 213 214 215 216 237 238 239 240 261 262 263 264 285 286 287 288 4.1 289 290 291

Product Information Sheet - R3501

Severinov, K. et al., J. Biol. Chem. 268, 14820, 1993. 20. Wehrli, W. et al., Biochim. Biophys. Acta, 157, 215, 1968. 21. Data for Biochemical Research, 274, 3rd ed. eds Dawson, R.M.C. et al. Oxford University

Examination of Non-Specifically Bound Proteins and Peptides Following Depletion of Twenty High Abundance Proteins from Human Plasma

IPI00430808 Hypothetical protein 179 3 217 3 2071 3 215 2 207 3 257 3 483 5 IPI00399007 Hypothetical protein DKFZp 250 4 269 3 274 5 347 4 156 4 102 3 253 4 352 7 IPI00784998

Programming data for Spectrophotometer and Spectroquant Test Kits

1.00961 CT 5 215 mg/l Ca 16 mm 565 DW 13 538 mg/l CaCO3 16 mm 7 301 mg/l CaO 16 mm 0.7 30.1 °d 16 mm 0.9 37.6 °e 16 mm 1.3 53.8 °f 16

Protocol: Human PYY (Total) ELISA Kit - 96-Well Plate

(Basal) 115 -- 130 -- 40 145 75% 171 103% 100 197 82% 232 102% 500 525 82% 658 106% C 0 (Basal) 144 -- 172

Product Information - CSAA1

Signal Transduction P y n/d n/d 214 Protein phosphatase 1α P7979 Signal Transduction P y n/d n/d 215 PTEN P7482 Signal Transduction P y n/d y 216 PTEN Clone:PTN-18 P3487 Signal Transduction M y y y

Protocol- EZHPYTT66K

97% B 0 (Basal) 115 - 130 - 40 145 75% 171 103% 100 197 82% 232 102% 500 525 82% 658 106% C 0 (Basal) 144 - 172 - 40 172

Product Information Sheet - 11758241001

BioTechniques 12, 643. 4 Lowry O. H. (1951) J. Biol. Chem. 193, 265. 5 Young D.C. et al. (1993) Anal. Biochem. 215, 24. 4. Supplementary Information Text Conventions To make information consistent and memorable

Eshmuno®CPS resin

buffer A (total protein concentration 43.0 mg/mL) • Load: 5 mL sample volume corresponding to 215 mg total protein • Column: 16 mm i.d. x 100 mm • Column volume: 20.1 mL • Residence time:

Product Information Sheet - ROAMYC

version: April 2016 y Version 06 Content version: April 2016 Store at 215 to 225°C Store at 2 2

OxyBlot¿ Protein Oxidation Detection Kit

cysteine protease-type cathepsin by singlet oxygen generated from naphthalene endoperoxides. BBRC 331:215-223. Periquet, M. et al. (2005) Proteomic analysis of parkin knockout mice: alterations in eneary

S&E Campaign Lab Tools - Tables for laboratory use

ArRNH2+, ArR2NH+ in TFA solution 13 12 11 10 9 8 7 6 5 4 3 2 1 0 13 12 11 10 9 8 7 6 5 4 3 2 1 0 H 13 12 11

Calbiochem Biologics 28.2

chymotrypsin-like activity of 20S proteasome (IC50 = 100 ng/ml). Does not affect peptidylglutamyl- 5 mg 215 peptide hydrolyzing (PGPH)-like activity even at 100 mg/ml. Inhibits α-chymotrypsin, cathepsin L and

Inhibitor Sourcebook 3rd Edition

........................... 215 239764 ........................................................... 215 239765 ........................................................... 215 239783 .....................

Katalog neoLab

.203 7-7591. . . . . . . . . . . . . . . . . .215 7-7915 to 7-7916 . . . . . . . . .403 7-8005 to 7-8009. . . .

User Guide Equinox SOP Software 2.1 for Windows XP

............................................................................ Inhalt — i 145 145 145 146 146 147 150 151 151 151 152 154 154 154 154 155 155 156 156 157 157 158 158 159 159 160

BRAND Katalog EN

Density bottles 170 Glass (Information) 295 - 297 Glass beakers 215 Graduated Beakers 217 Beakers with handle 217 Cylinders, Glass 145 - 147 Cylinders, Plastic 149, 150 Pipettes, Glass 133 - 138

Integration of Experimental and Computational Microfluidics in 3D Tissue Engineering

Engineered Chondrocyte Sys- tems Subject to Direct Perfusion,” Biorheology, Vol. 43, No. 3-4, 2006, pp. 215–222. [14] Raimondi, M. T., et al. “Engineered Cartilage Constructs Subject to Very Low Regimens

1/3